Brimonidine gel (Mirvaso▼): risk of exacerbation of rosacea

Some patients may have exacerbation or rebound symptoms of rosacea.

Show your support for reporting suspected adverse drug reactions

We are running a social media campaign to promote the reporting of suspected adverse drug reactions to the Yellow Card Scheme in support of an awareness week from 7 to 11 November 2016.

Letters sent to healthcare professionals in October 2016

A summary of recent safety letters sent to relevant healthcare professionals

Posted on the UK MHRA website on 8 November 2016